Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-01

Clinical Trial Update: Impact of Saccharin and Acesulfame-Potassium on Glycemia [NA]

View source ↗

Summary

A completed clinical trial from Virginia Tech evaluating the effect of saccharin and acesulfame potassium on glycemia in individuals with prediabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acesulfame potassium (acesulfame potassium)
  • Saccharin (saccharin)

Snippet

Sponsor: Virginia Polytechnic Institute and State University | Conditions: Prediabetes | NA | Status: COMPLETED